Activist hedge fund Irenic Capital Management has accumulated a stake in Papa John’s during the third quarter, adding a new layer to ongoing uncertainty surrounding the US pizza chain’s future, according to a report by Reuters.
Hillhouse, the Asia-focused investment firm led by Zhang Lei, has combined three of its public markets funds into a single vehicle valued at over $15bn, marking its largest fund reorganisation in years, according to a report by Bloomberg citing unnamed
Paul Singer’s activist investment firm Elliott Investment Management is seeking a stake in Integrated Diagnostics Holding (IDH), a London-listed healthcare company operating across the Middle East and Africa, according to a report by Bloomberg.
Third Point’s Dan Loeb said he remains confident about the US market outlook, noting that while volatility is inevitable, he is unconcerned by the Federal Reserve’s interest rate path and expects US equities to continue performing well, according to a
Activist hedge fund Jana Partners has taken a new position in Alkami Technology during the third quarter, according to a report by Reuters citing unnamed people familiar with the matter — a move that signals growing activist attention on the
Some of the largest US hedge funds, including Bridgewater, Tiger Global and Lone Pine, pared back positions in the so-called “Magnificent Seven” during the third quarter, while others upped their holdings or opened new positions, according to a report by
Man Group, the world’s largest listed hedge fund manager, plans to reduce its London-based workforce and relocate certain roles to its operations base in Bulgaria, signalling an accelerated cost-efficiency drive, according to a report by the Financial Times.
AQR Capital Management co-founder Cliff Asness says the quantitative investment firm is considering entering the sports betting market, according to a report by Bloomberg.
Citadel LLC has appointed Kevin Nassery, a former senior technology executive at crypto-exchange Gemini Trust Company, to lead its security and risk compliance for the Americas, according to a report by eFinancialCareers.
Shah Capital is pressing biotech firm Novavax’s board to explore strategic options, including a full sale, and warns it may launch a proxy fight if changes aren’t made within four months, according to a report by Reuters. The investor has
